Monitoring Glycemic Control

Canadian Journal of Diabetes

Volumn 37, Issue SUPPL.1, 2013, Pages

  Berard, Lori D ^a   Blumer, Ian ^a   Houlden, Robyn ^a   Miller, David ^a   Woo, Vincent ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; KETONE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ACCURACY; ARTICLE; BEHAVIOR CHANGE; BLOOD GLUCOSE MONITORING; BODY MASS; BODY WEIGHT; CANADA; CONTINUOUS GLUCOSE MONITORING; DIABETIC KETOACIDOSIS; FOREARM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HAND; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIFESTYLE MODIFICATION; MEDICAL DEVICE; MEDICAL SOCIETY; NOCTURNAL HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; THIGH; ANALYSIS; DIABETES MELLITUS; PRACTICE GUIDELINE;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CANADA; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 84876030454     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcjd.2013.01.017     Document Type: Article

References (74)

1. McCarter R.J., Hempe J.M., Chalew S.A. Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial. Diabetes Care 2006, 29:352-355.
2. Goldstein D., Little R., Lorenz R., et al. Tests of Glycemia in Diabetes. Diabetes Care 2004, 27:1761-1773.
3. Calisti L., Tognetti S. Measure of glycosylated hemoglobin. Acta Biomed 2005, 76(suppl 3):59-62.
4. American Diabetes Association Standards of medical care in diabetes-2007. Diabetes Care 2007, 30(suppl 1):S4-S41.
5. Sacks D.B., Bruns D.E., Goldstein D.E., et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002, 48:436-472.
6. American Diabetes Association Consensus statement on the worldwide standardization of the HbA1c measurement. Diabetologia 2007, 50:2042-2043. European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes FederationInternational Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation.
7. Consensus Committee Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007, 30:2399-2400.
8. Sacks D. Measurement of hemoglobin A1c: a new twist on the path to harmony. Diabetes Care 2012, 35:2674-2680.
9. Weykamp C., John W.G., Mosca A., et al. The IFCC reference measurement system for HbA1c: a 6-year progress report. Clin Chem 2008, 54:240-248.
10. Karter A.J., Ackerson L.M., Darbinian J.A., et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes Registry. Am J Med 2001, 111:1-9.
11. Karter A.J., Parker M.M., Moffet H.H., et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care 2006, 29:1757-1763.
12. Malekiani C.L., Ganesan A., Decker C.F. Effect of hemoglobinopathies on hemoglobin A1c measurements. Am J Med 2008, 121:e6.
13. Parkin C.G., Davidson J.A. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol 2009, 3:500-508.
14. Franciosi M., Pellegrini F., De Berardis G., et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care 2001, 24:1870-1877. QuED Study Group.
15. Norris S.L., Lau J., Smith S.J., et al. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002, 25:1159-1171.
16. Polonsky W.H., Earles J., Smith S., et al. Integrating medical management with diabetes self-management training: a randomized control trial of the Diabetes Outpatient Intensive Treatment program. Diabetes Care 2003, 26:3048-3053.
17. Polonsky W.H., Fisher L., Schikman C.H., et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care 2011, 34:262-267.
18. Sheppard P., Bending J.J., Huber J.W. Pre- and post-prandial capillary glucose self-monitoring achieves better glycaemic control than pre-prandial only monitoring. A study in insulin treated diabetic patients. Practical Diabetes Int 2005, 22:15-22.
19. Murata G.H., Shah J.H., Hoffman R.M., et al. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 2003, 26:1759-1763. Diabetes Outcomes in Veterans Study (DOVES).
20. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group.
21. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. The DCCT Research Group. Am J Med 1991, 90:450-459.
22. Gale E.A.M., Tattersall R.B. Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet 1979, 1:1049-1052.
23. Vervoort G., Goldschmidt H.M., van Doorn L.G. Nocturnal blood glucose profiles in patients with type 1 diabetes mellitus on multiple (> or =4) daily insulin injection regimens. Diabet Med 1996, 13:794-799.
24. Jones T.W., Porter P., Sherwin R.S., et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998, 338:1657-1662.
25. Boutati E.I., Raptis S.A. Self-Monitoring of blood glucose as part of the integral care of type 2 diabetes. Diabetes Care 2009, 32(suppl 2):S205-S210.
26. Faas A., Schellevis F.G., van Eijk J.T. The efficacy of self-monitoring of blood glucose in NIDDM subjects. A criteria-based literature review. Diabetes Care 1997, 20:1482-1486.
27. Harris M.I. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care 2001, 24:979-982. National Health and Nutrition Examination Survey (NHANES III).
28. Coster S., Gulliford M.C., Seed P.T., et al. Self-monitoring in type 2 diabetes mellitus: a meta-analysis. Diabet Med 2000, 17:755-761.
29. Welschen L.M., Bloemendal E., Nijpels G., et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005, 28:1510-1517.
30. Welschen L.M., Bloemendal E., Nijpels G., et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Cochrane Database Syst Rev 2005, 2:CD005060.
31. Davidson M.B., Castellanos M., Kain D., et al. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005, 118:422-425.
32. Davis W.A., Bruce D.G., Davis T.M. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care 2006, 29:1764-1770.
33. Davis W.A., Bruce D.G., Davis T.M. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia 2007, 50:510-515.
34. Farmer A., Wade A., Goyder E., et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007, 335:132.
35. Allemann S., Houriet C., Diem P., Stettler C. Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis. Curr Med Res Opin 2009, 25:2903-2914.
36. Jansen J.P. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006, 22:671-681.
37. McGeoch G., Derry S., Moore R.A. Self-monitoring of blood glucose in type-2 diabetes: what is the evidence?. Diabetes Metab Res Rev 2007, 23:423-440.
38. Poolsup N., Suksomboon N., Rattanasookchit S. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. Diab Technol Ther 2009, 11:775-784.
39. St John A., Davis W.A., Price C.P., Davis T.M.E. The value of self-monitoring of blood glucose: a review of recent evidence. J Diabetes Complications 2010, 24:129-141.
40. Towfigh A., Romanova M., Weinreb J.E., et al. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care 2008, 14:468-475.
41. Canadian Optimal Medication Prescribing and Utilization Service. Systematic review of use of blood glucose test strips for the management of diabetes mellitus. 2009. Available at. Accessed April 25, 2012. http://www.cadth.ca/media/pdf/BGTS_SR_Report_of_Clinical_Outcomes.pdf.
42. Skeie S., Kristensen G.B.B., Carlsen S., Sandberg S. Self-monitoring of blood glucose in type 1 diabetes patients with insufficient metabolic control: focused self-monitoring of blood glucose intervention can lower glycated hemoglobin A1C. J Diabetes Sci Technol 2009, 3:83-88.
43. Malanda U.L., Welschen L.M.C., Riphagen I.I., et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev 2012, 1:CD005060.
44. Franciosi M., Lucisano G., Pellegrini F. ROSES: role of self-monitoring of blood glucose and Intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med 2011, 28:789-796.
45. Duran A., Martin P., Runkle I., et al. Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes 2010, 2:203-211.
46. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
47. Sacks D.B., Bruns D.E., Goldstein D.E., et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002, 48:436-472.
48. Norris S.L., Engelgau M.M., Narayan K.M. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001, 24:561-587.
49. Bergenstal R., Pearson J., Cembrowski G.S., et al. Identifying variables associated with inaccurate self-monitoring of blood glucose: proposed guidelines to improve accuracy. Diabetes Educ 2000, 26:981-989.
50. Jungheim K., Koschinsky T. Glucose monitoring at the arm: risky delays of hypoglycemia and hyperglycemia detection. Diabetes Care 2002, 25:956-960.
51. Ellison J.M., Stegmann J.M., Colner S.L., et al. Rapid changes in postprandial blood glucose produce concentration differences at finger, forearm, and thigh sampling sites. Diabetes Care 2002, 25:961-964.
52. Bina D.M., Anderson R.L., Johnson M.L., et al. Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. Diabetes Care 2003, 26:981-985.
53. Jungheim K., Koschinsky T. Glucose monitoring at the thenar: evaluation of upper dermal blood glucose kinetics during rapid systemic blood glucose changes. Horm Metab Res 2002, 34:325-329.
54. Guerci B., Benichou M., Floriot M., et al. Accuracy of an electrochemical sensor for measuring capillary blood ketones by finger stick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care 2003, 26:1137-1141.
55. Bektas F., Eray O., Sari R., et al. Point of care blood ketone testing of diabetic patients in the emergency department. Endocr Res 2004, 30:395-402.
56. Khan A.S., Talbot J.A., Tieszen K.L., et al. Evaluation of a bedside blood ketone sensor: the effects of acidosis, hyperglycaemia and acetoacetate on sensor performance. Diabet Med 2004, 21:782-785.
57. Guerci B., Floriot M., Böhme P., et al. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care 2003, 26:582-589.
58. Deiss D., Bolinder J., Riveline J.P., et al. Improved glycemic values control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006, 29:2730-2732.
59. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008, 359:1464-1476. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.
60. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009, 32:1378-1383. Juvenile Diabetes Research Foundation. Continuous Glucose Monitoring Study Group.
61. Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care 2009, 32:2047-2049. Juvenile Diabetes Research Foundation. Continuous Glucose Monitoring Study Group.
62. O'Connell M.A., Donath S., O'Neal D.N., et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia 2009, 52:1250-1257.
63. Raccah D., Sulmont V., Reznik Y., et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes. Diabetes Care 2009, 32:2245-2250.
64. Effectiveness of continuous glucose monitoring in a clinical care environment. Diabetes Care 2010, 33:17-22. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group.
65. Battelino T., Phillip M., Bratina N., et al. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011, 34:795-800.
66. Bergenstal R.M., Tamborlane W.V., Ahmann A., et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010, 363:311-320.
67. Chase H.P., Beck R.W., Xing D., et al. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol Ther 2010, 12:507-515.
68. Yoo H.J., An H.G., Park S.Y., et al. Use of a real-time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract 2008, 82:73-79.
69. Garg S., Voelmle M., Beatson C., et al. Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy. Diabetes Care 2011, 34:574-579.
70. Cosson E., Hamo-Tchatchouang E., Dufaitre-Patouraux L., et al. Multicentre, randomised, controlled study of the impact of continuous subcutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients. Diabetes Metab 2009, 35:312-318.
71. Murphy H.R., Rayman G., Lewis K., et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 2008, 337:a1680.
72. Hirsch I.B., Abelseth J., Bode B.W., et al. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 2008, 10:377-383.
73. Rohlfing C.L., Wiedmeyer H.M., Little R.R., et al. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002, 25:275-278.
74. Goldenberg R.M., Cheng A.Y.Y., Punthakee Z., Clement M. Use of glycated hemoglobin (A1C) in the diagnosis of type 2 diabetes mellitus in adults. Can J Diab 2011, 35:247-249.